ClinicalTrials HQ

A Phase 2, Baseline-Controlled Study Evaluating the Safety and Efficacy of PTX-022 (Sirolimus) Topical Gel 3.9% in the Treatment of Cutaneous Venous Malformations

A Phase 2, Baseline-Controlled Study Evaluating the Safety and Efficacy of PTX-022 (Sirolimus) Topical Gel 3.9% in the Treatment of Cutaneous Venous Malformations

Active, not recruiting · NCT06653842 · Registry updated 2026-03-27
Ask about research services

Clinical trials

Swipe the table sideways for more columns.

TrialConditionsStatusPhaseUpdatedMore infoNCT ID
A Phase 2, Baseline-Controlled Study Evaluating the Safety and Efficacy of PTX-022 (Sirolimus) Topical Gel 3.9% in the Treatment of Cutaneous Venous MalformationsCutaneous Venous MalformationsActive, not recruitingPhase 22026-03-27NCT06653842

1 results · Page 1 of 1

Organizations

Swipe the table sideways for more columns.

OrganizationsLinked trials
Palvella Therapeutics, Inc.4

10 results · Page 1 of 1

Research sites

Swipe the table sideways for more columns.

Research sitesCityCountryLinked trials
Children's Hospital of Orange CountyIrvineUnited States2
Children's Hospital of PhiladelphiaPhiladelphiaUnited States434
Cleveland ClinicClevelandUnited States558
Colorado Children's HospitalAuroraUnited States7
Johns HopkinsBaltimoreUnited States39
Mayo ClinicRochesterUnited States664
Minnesota Clinical Study CenterNew BrightonUnited States13
Stanford UniversityPalo AltoUnited States51
University of North CarolinaChapel HillUnited States5
University of Utah HealthSalt Lake CityUnited States2